Latest Headlines
-
CDMO Veranova Breaks Ground On ADC Manufacturing Facility Expansion In Massachusetts
6/25/2025
Government officials, industry leaders, and local business representatives gathered yesterday to mark the groundbreaking of Veranova’s latest expansion at its Devens, Massachusetts facility.
-
Blue Mountain Launches Spring 2025 RAM Release, Advancing Asset Management For Life Sciences
6/25/2025
Blue Mountain, the leader in GMP-compliant Enterprise Asset Management (EAM) software for life sciences, announces the launch of its Spring 2025 RAM Release, introducing advanced capabilities that drive operational excellence, maximize compliance, and empower mobile teams across the Life Sciences industry.
-
Angstrom Life Science Solutions Establishes New Business Unit for Cleanroom Design and Construction Offerings
6/25/2025
Angstrom Technology, a global leader in cleanroom design, construction, and maintenance, today announced the strategic rebranding of its specialized Life Sciences division. The division will now operate as a separate business unit under the name Angstrom Life Science Solutions.
-
AGC Biologics Expands Cell Therapy Development Operations To Asia To Serve Growing Market Need
6/25/2025
Today, we announced we will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC Inc.’s Yokohama Technical Center, marking the latest step in the global expansion of the company’s Global Cell and Gene Technologies Division. The improved geographical footprint allows AGC Biologics to better serve customers requiring autologous and allogeneic products across all markets, with cell therapy manufacturing now available in three continents (Milan, Italy – Longmont, Colorado, U.S. – Yokohama, Japan).
-
CDMO 1Elevan Biopharmaceuticals Relocating Manufacturing Facility To Fishers Indiana
6/24/2025
1Elevan Biopharmaceuticals has officially announced its relocation from California to Fishers, Indiana, establishing its new headquarters in the Fishers Life Sciences and Innovation Park. The move represents a $7 million investment in a next-generation facility that will serve as the company's primary operations center.
-
CRDMO Aragen Completes Facility And Equipment Qualification; First GMP batches In Late July 2025
6/20/2025
Aragen, a leading contract research, development and manufacturing organization (CRDMO), announced that it will commence GMP manufacturing at its biologics manufacturing facility in Bangalore, India from late July 2025. Aragen has successfully completed the facility and equipment qualification and demonstrated the productivity of its intensified fed batch cell culture manufacturing platform to deliver titers >25 g/L.
-
Ross Offers Factory Reconditioning Program For Mixers And Blenders
6/20/2025
Ross Mixers offers refurbished equipment through its factory reconditioning program.This initiative allows customers to purchase mixers that have been meticulously restored to "like-new" condition by the company's original equipment manufacturer (OEM) team.The reconditioning process includes thorough inspection, repair, re-polishing, and testing of all components to ensure optimal performance.
-
Pharmaceutical Packaging Equipment Auction Announced
6/20/2025
Don’t miss the latest Federal Equipment and Proxio Group auction featuring high-quality packaging equipment—pharma-origin with multi-industry use—including fillers, cappers, labelers, and more. The auction event runs June 23–July 9, 2025.
-
BASF Opens Dedicated GMP Manufacturing Site For Biopharma Ingredients In Michigan
6/20/2025
BASF opens its new Good Manufacturing Practice (GMP) Solution Center, in Wyandotte, Michigan. This investment underscores the ongoing commitment of BASF to providing innovative solutions in the biopharma and pharmaceutical ingredients industries, including the reliable supply of bioprocessing ingredients and excipients for biopharma applications as well as small molecules.
-
CDMO FAREVA Announces Significant Isolator Equipment Upgrades To France Manufacturing Facility
6/20/2025
At its Pau site, FAREVA continues to drive pharmaceutical innovation with the opening of a new GMP sterile pilot unit dedicated to the production of liquid and lyophilized injectable forms.